Category:FDA approved in 2014

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 00:02, 16 February 2014 by PeterYang (talk | contribs) (Created page with "Medications in this category received their initial FDA approval in 2014.")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Medications in this category received their initial FDA approval in 2014.

Pages in category "FDA approved in 2014"

The following 12 pages are in this category, out of 12 total.

B

C

Ceritinib (Zykadia)

I

Idelalisib (Zydelig)

M

Mercaptopurine (6-MP)

N

O

Olaparib (Lynparza)

P

Pembrolizumab (Keytruda)

R

Ramucirumab (Cyramza)

S

Siltuximab (Sylvant)

V

Vorapaxar (Zontivity)

Retrieved from "https://hemonc.org/w/index.php?title=Category:FDA_approved_in_2014&oldid=4354"